# FDA recall D-0149-2024

> **Siegfried Barbera, SL** · Class III · drug recall initiated 2023-11-20.

## Product

Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66

## Reason for recall

Failed Dissolution Specifications

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0149-2024
- **Recalling firm:** Siegfried Barbera, SL
- **Classification:** Class III
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2023-11-20
- **Report date:** 2023-12-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Barbera Del Valles, N/A, Spain

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0149-2024

## Citation

> AI Analytics. FDA recall D-0149-2024. Retrieved 2026-07-13 from https://api.ai-analytics.org/recall/D-0149-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*